Suchergebnisse - "Geenen, Jill J"

PubPharm (7)

1

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer : A biomarker-enriched phase II study

enthalten in: Gynecologic oncology | 2023

von Embaby, A. | Kutzera, J. | Geenen, J. | +12

2

Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer : An Open-Label, Four-Arm, Phase II Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Moore, K. | Chambers, S. | Hamilton, E. | +17

CommentOn: Clin Cancer Res. 2022 Jan 1;28(1):1. - PMID 34987032

3

A Phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy in patients with advanced cancer

enthalten in: International journal of cancer | 2021

von Geenen, J. | Dackus, G. | Schouten, P. | +8

4

PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer

enthalten in: Clinical pharmacokinetics | 2018

von Geenen, J. | Linn, S. | Beijnen, J. | +1

5

PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer

enthalten in: Clinical pharmacokinetics | 2018

von Geenen, J. | Linn, S. | Beijnen, J. | +1

6

PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer

enthalten in: Clinical pharmacokinetics | 2017

von Geenen, J. | Linn, S. | Beijnen, J. | +1

7

Molecular Pathways : Targeting the Protein Kinase Wee1 in Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Geenen, J. | Schellens, J.

1
[1]